Quantcast

Latest Ciprofloxacin Stories

2008-06-20 12:00:07

Aradigm has started a multicenter Phase II clinical trial of its inhaled liposomal ciprofloxacin in adult patients with non-cystic fibrosis bronchiectasis. Following an antibiotic washout period, 36 patients will be enrolled to receive daily inhaled liposomal ciprofloxacin for a period of 28 consecutive days. The primary efficacy endpoint will be treatment of respiratory infection measured as the change in the density of Pseudomonas aeruginosa bacterial colony forming units in the sputum...

2008-06-19 09:00:08

Aradigm Corporation (OTCBB: ARDM) (the "Company") today announced it has initiated a multicenter Phase 2 clinical trial of its inhaled liposomal ciprofloxacin in adult patients with non-cystic fibrosis bronchiectasis. Following an antibiotic washout period, 36 patients will be enrolled to receive daily inhaled liposomal ciprofloxacin for a period of 28 consecutive days. The primary efficacy endpoint will be treatment of respiratory infection measured as the change in the density of...

2008-06-17 06:00:43

Depomed, Inc. (NASDAQ:DEPO) announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for U.S. patent application number 10/280,309. Paul B. Simboli, Depomed's director of Intellectual Property, noted that the patent contains claims directed to methods for treating neuropathic pain and claims related to methods for delivering compounds via specific dosage form technologies. Carl A. Pelzel, Depomed's president and chief executive officer,...

2007-11-10 06:00:08

By Albrecht, Uwe Goos, Karl-Heinz; Schneider, Berthold Key words: Lower urinary tract infections - UTI - Relapses - Tropaeoli majoris herba - Armoraciae rusticanae radix ABSTRACT Objectives: The aim of this study was to verify the efficacy and safety of a herbal medicinal product containing Tropaeoli majoris herba and Armoraciae rusticanae radix in the prophylactic treatment of chronically recurrent urinary tract infections (UTIs), and to test whether the medicinal product decreases the...

2006-08-29 11:05:52

LOS ANGELES (Reuters) - The group of antibiotics that includes Bayer AG's Cipro should carry "black box" warnings about a higher risk of ruptured tendons, the Illinois Attorney General and a consumer group told federal health regulators on Tuesday. The Illinois petition follows a request made in May 2005 that urged the U.S. Food and Drug Administration to require manufacturers of the antibiotics to revise drug labels and inform doctors of the risk. Consumer group Public Citizen said...

2006-07-10 12:28:26

NEW YORK (Reuters Health) - The food-contaminating bug E. coli -- which can cause diarrhea, urinary tract infections and more severe illness in humans -- appears to be developing resistance to antibiotics called fluoroquinolones in chickens, a study shows. The problem is arising largely because of antibiotic treatment of the animals, which forces the microbes to mutate and become resistant. Food-borne resistant E. coli can then be transmitted to humans. Action to interrupt the...

2006-05-01 16:05:00

By Maggie Fox, Health and Science Correspondent WASHINGTON -- Combining an anthrax vaccine with a short course of antibiotics completely protected monkeys who inhaled spores of the often-deadly bacteria, offering perhaps a more realistic way to protect people in case of a biological attack, researchers said on Monday. The finding suggests it may be possible to vaccinate people who have been exposed to anthrax spores, and give them a short, two-week course of antibiotics to provide extra...

2006-05-01 16:00:00

By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - Combining an anthrax vaccine with a short course of antibiotics completely protected monkeys who inhaled spores of the often-deadly bacteria, offering perhaps a more realistic way to protect people in case of a biological attack, researchers said on Monday. The finding suggests it may be possible to vaccinate people who have been exposed to anthrax spores, and give them a short, two-week course of antibiotics to provide...

2005-12-03 02:15:00

NEW YORK -- Two reports highlight the emergence of a new, highly toxic strain of the bacterium Clostridium difficile that is resistant to fluoroquinolone antibiotics, such as Cipro (ciprofloxacin) and Levaquin (levofloxacin), and is causing geographically dispersed outbreaks. The reports were released early by The New England Journal of Medicine to coincide with this week's report by the Centers for Disease Control and Prevention C. difficile infections in low-risk patients. C. difficile is a...

2005-11-17 14:22:55

By David Douglas NEW YORK (Reuters Health) - Once-daily use of a new extended release (ER) formulation of the antibiotic ciprofloxacin is as effective as twice-daily intermediate-release (IR) ciprofloxacin in clearing up urinary infection in women, according to researchers. Ciprofloxacin ER (brand name Proquin XR, made by Depomed) "showed efficacy that was clearly at least as good as ciprofloxacin IR twice daily," investigator Dr. Bret Berner told Reuters Health. Dr. Berner, of...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related